Table 2 Patient characteristics (n = 130)
Characteristic | Value or No. of patients (%) |
|---|---|
Age, years | |
Median | 74 |
Range | 48–91 |
FEV1, % of predicted | |
Median | 42 |
Range | 15–123 |
Staging PET SUVmax | |
Median | 6.20 |
Range | 0.5–32.6 |
Gross tumor volume, cm3 | |
Median | 9.6 |
Range | 0.7–51.47 |
Planning target volume, cm3 | |
Median | 73.2 |
Range | 23.36–109.64 |
Sex | |
Men | 67 (51.5) |
Women | 63 (48.5) |
COPD stage | |
0-II | 73 (56) |
III-IV | 57 (44) |
History of other types of cancer | |
Yes | 37 (28.5) |
No | 93 (71.5) |
ECOG performance status | |
0 or 1 | 81 (62) |
2 or 3 | 49 (38) |
Lung cancer stage | |
IA (T1) | 112 (86) |
IB (T2) | 18 (14) |
Lung cancer histology | |
Squamous cell carcinoma | 36 (28) |
Adenocarcinoma | 58 (45) |
NSCLC not specified | 36 (28) |
Disease status | |
Medically inoperable | 96 (74) |
Operable | 34 (26) |
Tumor location | |
Peripheral | 119 (91.5) |
Central | 11 (8.5) |